GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » HPGC Renmintongtai Pharmaceutical Corp (SHSE:600829) » Definitions » ROE % Adjusted to Book Value

HPGC Renmintongtai Pharmaceutical (SHSE:600829) ROE % Adjusted to Book Value : 8.32% (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is HPGC Renmintongtai Pharmaceutical ROE % Adjusted to Book Value?

HPGC Renmintongtai Pharmaceutical's ROE % for the quarter that ended in Mar. 2024 was 11.23%. HPGC Renmintongtai Pharmaceutical's PB Ratio for the quarter that ended in Mar. 2024 was 1.35. HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 was 8.32%.


HPGC Renmintongtai Pharmaceutical ROE % Adjusted to Book Value Historical Data

The historical data trend for HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

HPGC Renmintongtai Pharmaceutical ROE % Adjusted to Book Value Chart

HPGC Renmintongtai Pharmaceutical Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
ROE % Adjusted to Book Value
Get a 7-Day Free Trial Premium Member Only Premium Member Only 7.29 3.50 7.47 7.57 6.79

HPGC Renmintongtai Pharmaceutical Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
ROE % Adjusted to Book Value Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 7.37 8.12 7.76 4.59 8.32

Competitive Comparison of HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value

For the Drug Manufacturers - Specialty & Generic subindustry, HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value falls into.



HPGC Renmintongtai Pharmaceutical ROE % Adjusted to Book Value Calculation

HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.21% / 1.65
=6.79%

HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2024 is calculated as

ROE % Adjusted to Book Value=ROE % / PB Ratio
=11.23% / 1.35
=8.32%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


HPGC Renmintongtai Pharmaceutical ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of HPGC Renmintongtai Pharmaceutical's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.


HPGC Renmintongtai Pharmaceutical (SHSE:600829) Business Description

Traded in Other Exchanges
N/A
Address
No. 76 Hengshan Road, Nangang District, Heilongjiang Province, Harbin, CHN, 150076
HPGC Renmintongtai Pharmaceutical Corp, formerly Harbin Pharm. Group Sanjing Pharmaceutical Shareholding Co Ltd is engaged in the production and sale of pharmaceuticals products in China.
Executives
Yue Xian Zhi senior management
Zhang Li Jun Director

HPGC Renmintongtai Pharmaceutical (SHSE:600829) Headlines

No Headlines